DD107670A5 - Verfahren zur herstellung von dopaminderivaten - Google Patents

Verfahren zur herstellung von dopaminderivaten

Info

Publication number
DD107670A5
DD107670A5 DD170118A DD17011873A DD107670A5 DD 107670 A5 DD107670 A5 DD 107670A5 DD 170118 A DD170118 A DD 170118A DD 17011873 A DD17011873 A DD 17011873A DD 107670 A5 DD107670 A5 DD 107670A5
Authority
DD
German Democratic Republic
Prior art keywords
preparation
dopamine derivatives
dopamine
derivatives
Prior art date
Application number
DD170118A
Other languages
English (en)
Other versions
DD107670B3 (de
Inventor
Ronald R Tuttle
Jack Mills
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DD107670(A5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DD107670A5 publication Critical patent/DD107670A5/de
Publication of DD107670B3 publication Critical patent/DD107670B3/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46Friedel-Crafts reactions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD73170118A 1972-04-12 1973-04-12 Verfahren zur herstellung von (3.4-dihydroxy-n-)3-(4-hydroxyphenyl)-1-methyl-n-propyl/-beta-phenethyl-amin DD107670B3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24346672A 1972-04-12 1972-04-12

Publications (2)

Publication Number Publication Date
DD107670A5 true DD107670A5 (de) 1974-08-12
DD107670B3 DD107670B3 (de) 1988-04-06

Family

ID=22918877

Family Applications (1)

Application Number Title Priority Date Filing Date
DD73170118A DD107670B3 (de) 1972-04-12 1973-04-12 Verfahren zur herstellung von (3.4-dihydroxy-n-)3-(4-hydroxyphenyl)-1-methyl-n-propyl/-beta-phenethyl-amin

Country Status (31)

Country Link
JP (2) JPS5825656B2 (de)
KR (1) KR790000113B1 (de)
AR (1) AR203822A1 (de)
AT (1) AT323719B (de)
AU (1) AU472734B2 (de)
BE (1) BE798051A (de)
BG (1) BG23001A3 (de)
CA (1) CA1018188A (de)
CH (2) CH569691A5 (de)
CS (2) CS190406B2 (de)
CY (1) CY963A (de)
DD (1) DD107670B3 (de)
DE (1) DE2317710C2 (de)
DK (1) DK142750C (de)
ES (1) ES413639A1 (de)
FR (1) FR2182947B1 (de)
GB (1) GB1392674A (de)
HK (1) HK50178A (de)
HU (2) HU167597B (de)
IE (1) IE37511B1 (de)
IL (1) IL42016A (de)
KE (1) KE2870A (de)
MY (1) MY7800381A (de)
NL (1) NL174459C (de)
PH (1) PH11041A (de)
PL (2) PL90695B1 (de)
RO (2) RO65105A (de)
SE (1) SE399064B (de)
SU (1) SU496719A3 (de)
YU (2) YU36483B (de)
ZA (1) ZA732136B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH585693A5 (de) * 1974-02-08 1977-03-15 Ciba Geigy Ag
US4342692A (en) * 1980-10-20 1982-08-03 Usv Pharmaceutical Corporation Pyrrolidines
ZA825227B (en) * 1981-07-22 1984-03-28 Syntex Inc Substituted pyrrolidine cardiovascular system regulators antihypertensives
JPS6061523A (ja) * 1983-09-16 1985-04-09 Shionogi & Co Ltd 経口用ドブタミン製剤
ZA881076B (en) * 1987-02-24 1989-10-25 Lilly Co Eli Dobutamine salts
JPH0383364U (de) * 1989-12-18 1991-08-23
AU658188B2 (en) * 1991-05-20 1995-04-06 Tsumura & Co. Phellodendrine analogs and allergy type IV suppressor containing the same as active ingredient
ATE155125T1 (de) * 1993-04-13 1997-07-15 Duphar Int Res Herstellung von dobutamin verbindungen
EP0620208B1 (de) * 1993-04-13 1997-07-09 Duphar International Research B.V Herstellung von Dobutamin Verbindungen
WO2004031129A2 (en) 2002-10-03 2004-04-15 New Era Biotech, Ltd. Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
CA2560922C (en) 2004-03-26 2014-01-07 New Era Biotech, Ltd. Improvements in or relating to compounds for use in the treatment of aids and other viral diseases and hiv-related infections and compositions containing such compounds, methods of treating such diseases and infections and methods of making such compounds and compositions
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
US9192585B2 (en) 2009-07-31 2015-11-24 Cognition Therapeutics, Inc. Inhibitors of cognitive decline
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
EP2747759A4 (de) * 2011-08-25 2015-05-13 Cognition Therapeutics Inc Zusammensetzungen und verfahren zur behandlung neurodegenerativer erkrankungen
AU2015210852B2 (en) 2014-01-31 2019-01-24 Cognition Therapeutics, Inc. Isoindoline compositions and methods for treating neurodegenerative disease
DK3634394T3 (da) 2017-05-15 2026-03-02 Cognition Therapeutics Inc Sammensætninger til behandling af neurogenerative sygdomme
CN114524734B (zh) * 2021-12-27 2024-04-26 嘉实(湖南)医药科技有限公司 一种盐酸多巴酚丁胺的制备方法
CN117326958B (zh) * 2023-09-21 2025-07-11 锦州奥鸿药业有限责任公司 一种高纯度盐酸多巴酚丁胺的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2276619A (en) * 1942-03-17 N-phentlaliphatic-dihtoroxyphentnl

Also Published As

Publication number Publication date
DK142750C (da) 1981-08-17
NL174459C (nl) 1984-06-18
CA1018188A (en) 1977-09-27
PH11041A (en) 1977-10-25
BE798051A (fr) 1973-10-11
AT323719B (de) 1975-07-25
JPS497237A (de) 1974-01-22
AU5438573A (en) 1974-10-17
IE37511B1 (en) 1977-08-03
JPS58131945A (ja) 1983-08-06
YU36483B (en) 1984-02-29
KR790000113B1 (en) 1979-03-20
HU167597B (de) 1975-11-28
HK50178A (en) 1978-09-15
RO65105A (ro) 1980-01-15
DD107670B3 (de) 1988-04-06
CS190406B2 (en) 1979-05-31
MY7800381A (en) 1978-12-31
IL42016A (en) 1976-05-31
CH580563A5 (de) 1976-10-15
CY963A (en) 1978-12-22
YU321279A (en) 1983-04-27
GB1392674A (en) 1975-04-30
HU166213B (de) 1975-02-28
DK142750B (da) 1981-01-12
JPS6221343B2 (de) 1987-05-12
NL7305097A (de) 1973-10-16
ZA732136B (en) 1974-03-27
JPS5825656B2 (ja) 1983-05-28
RO70892A (ro) 1982-02-26
NL174459B (nl) 1984-01-16
AR203822A1 (es) 1975-10-31
ES413639A1 (es) 1976-01-16
CH569691A5 (de) 1975-11-28
DE2317710C2 (de) 1983-08-04
KE2870A (en) 1978-09-01
DE2317710A1 (de) 1973-10-18
PL90695B1 (de) 1977-01-31
YU37113B (en) 1984-08-31
BG23001A3 (bg) 1977-05-20
FR2182947A1 (de) 1973-12-14
CS190448B2 (en) 1979-05-31
IL42016A0 (en) 1973-06-29
YU97673A (en) 1982-02-25
SU496719A3 (ru) 1975-12-25
SE399064B (sv) 1978-01-30
FR2182947B1 (de) 1976-07-02
AU472734B2 (en) 1976-06-03
PL94207B1 (de) 1977-07-30

Similar Documents

Publication Publication Date Title
AT340590B (de) Verfahren zur herstellung von neuen 7-acylaminocephalosporinderivaten
AT327190B (de) Verfahren zur herstellung von 1-hydroxi-2-pyridonen
AT326668B (de) Verfahren zur herstellung von chinazolinonderivaten
AT330143B (de) Verfahren zur herstellung von 2-substituierten 4-hydroxy -2- cyclopenten -1- onen
AT330766B (de) Verfahren zur herstellung von neuen sulfamoylphenylimidazolidinonderivaten
AT320626B (de) Verfahren zur Herstellung von isopropylamin-Derivaten
AT320627B (de) Verfahren zur Herstellung von α-Deoxytetracyclinen
AT326648B (de) Verfahren zur herstellung von 2-nitro-benzofuranderivaten
AT336009B (de) Verfahren zur herstellung von 2-amino-2-oxazolinen
AT328456B (de) Verfahren zur herstellung von chinazolinonderivaten
CH543535A (de) Verfahren zur Herstellung von Thiazolderivaten
AT326115B (de) Verfahren zur herstellung von neuen 5-acylpyrrolderivaten
AT331240B (de) Verfahren zur herstellung von 4-chlor-2-hydroxybenzothiazol
AT332400B (de) Verfahren zur herstellung von neuen 4-phenylaminopyridinderivaten
AT337163B (de) Verfahren zur herstellung von n-aminoathylbenzamiden
AT321924B (de) Verfahren zur herstellung von 1-hydrazino-phthalazin-hydrochlorid
AT332875B (de) Verfahren zur herstellung von benzodiazepin -2-on- derivaten
AT328080B (de) Verfahren zur herstellung von 7-acylamido-7-alkoxycephalosporinverbindungen
AT320657B (de) Verfahren zur Herstellung von 3-Phenyl-6-halogen-pyridazinverbindungen
AT329776B (de) Verfahren zur herstellung von benzochinolizin-derivaten
AT333261B (de) Verfahren zur herstellung von n-aminoalkylbenzamiden
AT317123B (de) Verfahren zur Herstellung von 3-Fluor-D-alanin
ATA938773A (de) Verfahren zur herstellung von n-aminoalkylbenzamiden
ATA573073A (de) Verfahren zur herstellung von benzocycloheptaoxazolonen
AT301029B (de) Verfahren zur Herstellung von neuen N-Arylidenderivaten von Erythromycylamin